NCT01370447No Longer Available不适用
Emergency Use Protocol for EPI-743 in Acutely Ill Patients With Inherited Mitochondrial Respiratory Chain Disease Within 90 Days of End-of-Life Care
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
- 试验地点
- 16
研究概览
简要总结
This study will evaluate the safety and efficacy of EPI-743 in participants with severe mitochondrial respiratory chain diseases who are considered to be within 90 days of end-of-life care.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 1 Year 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (16)
Loading locations...
相似试验
No Longer Available
不适用
Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]Leber's Hereditary Optic NeuropathyNCT02300753Edison Pharmaceuticals Inc
已完成
2 期
EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological ImpairmentMethylmalonic Aciduria and Homocystinuria,Cblc TypeRetinopathyGenetic DiseaseNCT01793090Bambino Gesù Hospital and Research Institute30
已完成
2 期
A Study of ET-743 (Trabectedin) in Patients With Advanced Breast CancerBreast NeoplasmsNeoplasmsNeoplasms by SiteBreast DiseasesSkin DiseasesNCT00050427Johnson & Johnson Pharmaceutical Research & Development, L.L.C.53
终止
1 期
A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)Prostatic NeoplasmsNCT05295927Janssen Research & Development, LLC3
已完成
2 期
E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue SarcomaSoft Tissue SarcomaNCT00413192Eisai Inc.128